Printful and Printify Announce Strategic Leadership Team and New Board for the Merged Company
Printful and Printify, two pioneering technology platforms, have announced their merger and unveiled the leadership team for the newly unified company. Alex Saltonstall, formerly CEO of Printful, will lead as the CEO of the merged company, while Anastasija Oleinika, CEO of Printify, will take on the role of President and Head of Platform. The strategic leadership team, composed of executives from both companies, officially begins its joint work today, November 20th.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241120769167/en/
New Strategic Leadership Team. (Photo: Printful & Printify)
Jānis (James) Berdigans, Co-Founder, Printify: “Our newly formed A-team of superheroes is ready to embark on its mission to deliver even more exceptional innovation and experiences to our existing and future customers.”
Lauris Liberts, Co-Founder, Printful: “This is an exciting moment for us. We truly believe that this newly formed management team will elevate the company and the industry to new heights. Alex’s strategic vision will guide the unified organization, while Anastasija will focus on platform strategy and operations, driving integration priorities and enhancing brand and technology strategies. Together with the combined talent from both companies, we’re excited about our new team.”
Alex Saltonstall, CEO: “I’m thrilled by the strategic opportunity in front of us. Our focus will be on strengthening relationships with customers, partners, and other stakeholders to drive growth and long-term success. In parallel we will start with the incredible talent from both companies and develop a world-class team, while fostering a strong and empowered company culture. Together, we’ll build a unique company known for enabling the long-term growth of our merchants and clients with innovative and unparalleled solutions.”
Anastasija Oleinika, President and Head of Platform: “My passion has always been about creating seamless, user-friendly experiences that remove barriers and unlock opportunities. The newly formed team will combine the best talents, complementing each other's strengths to create synergy that will enhance our overall performance.”
The board will consist of co-founders Jānis (James) Berdigans (Printify) and Lauris Liberts (Printful), along with Alex Saltonstall, CEO, and Anastasija Oleinika, President and Head of Platform. They’ll be joined by longtime advisors to Printify and Printful, as well as Silicon Valley stalwarts Gokul Rajaram (Google, Pinterest, DoorDash) and Ernst Teunissen (Tripadvisor, Criteo, Just Eat), with a soon-to-be-appointed seventh independent member.
The unified leadership team features experienced executives from both Printful and Printify to ensure a seamless integration and dynamic growth trajectory:
- Alex Saltonstall, Chief Executive Officer of Printful, will lead the merged company as CEO.
- Anastasija Oleinika, Chief Executive Officer of Printify, will serve as President & Head of Platform.
The rest of the leadership team will be as follows:
- Adam Malpocher – Chief Financial Officer
- Edgars Peičs – Chief Technology Officer
- Zane Levsa – Chief Operating Officer
- Ashish Chopra –Chief Product Officer
- Pārsla Basko – Chief People & Culture Officer
- Greg Sewastianowicz – Chief Growth Officer for the Platform business
- Sarah Praceus – Vice President of Commerce
- Rick Simpson – Founder of Snow Commerce, will remain Head of Snow Commerce.
On November 5, 2024, Printful and Printify announced their merger as equal partners. Following approval from regulatory authorities and full shareholder support, the merger transaction has been completed and the newly formed strategic leadership team will begin the integration process on November 20th with a focus on uniting teams, combining technology capabilities, and pooling resources to expand product selection, geographic reach, and fulfillment solutions. Both the Printful and Printify platforms will continue to operate as separate brands under a holding company, the name of which is currently being developed.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241120769167/en/
Contacts
Contact for media:
Janīna Biteniece
Deep White
E: janina@deepwhite.lv
M: +37126706361
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 12:00:00 CET | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currently conducting a global, multi-center Phase 1 clinical trial (NCT06427941) to explore the safety and anti-tumor activity of BGB-B2033, both alone and in combination with PD-1 inhibitor TEVIMBRA® (tisle
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press Release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press Release
Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press Release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press Release
Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom